China Universal Asset Management Co., Ltd. Anavex Life Sciences Corp. Transaction History
China Universal Asset Management Co., Ltd.
- $1.17 Billion
- Q3 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 15,056 shares of AVXL stock, worth $54,803. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,056
Previous 17,147
12.19%
Holding current value
$54,803
Previous $158,000
15.82%
% of portfolio
0.01%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding AVXL
# of Institutions
213Shares Held
32.1MCall Options Held
1.82MPut Options Held
1.09M-
Black Rock Inc. New York, NY6.39MShares$23.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$18.6 Million0.0% of portfolio
-
State Street Corp Boston, MA3.29MShares$12 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.03MShares$7.38 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY1.04MShares$3.77 Million0.02% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $284M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...